Contextual Main Account News

Our Commitment to Cancer Care During COVID-19

Healthcare systems and providers around the world are coming together and adapting quickly to deliver care to patients under extraordinary circumstances as the coronavirus pandemic evolves. Our own purview as a company is cancer care. Cancer patients are already impacted in areas hard hit by the pandemic as hospital and laboratory resources come under strain. While our team has been …

Contextual Main Account News

Contextual Genomics and EORLA Partner for Early Access to ctDNA Cancer Testing

VANCOUVER, British Columbia & OTTAWA, Ontario — Contextual Genomics, a leading cancer genomics company, and Eastern Ontario Regional Laboratory Association (EORLA), a nonprofit organization offering high quality, patient focused, hospital-based lab services in Eastern Ontario, announced that they have partnered to bring Contextual Genomics’ ctDNA cancer genomic testing to EORLA’s Champlain Local Health Integration Network (CLHIN) of Eastern Ontario, Canada. …

Contextual Main Account News

Contextual Genomics and Lab Genomics Partner for Liquid Biopsy Cancer Testing

VANCOUVER, British Columbia & FOUNTAIN VALLEY, California (BUSINESS WIRE)–Contextual Genomics, a leading cancer genomics company, and Lab Genomics, a personalized medicine company providing state of the art molecular genetic testing in Southern California, announced that they have signed an agreement enabling Lab Genomics to offer Contextual Genomics’ quality assured Next Generation Sequencing (NGS) based ctDNA cancer genomic testing to patients …

Contextual Main Account News

Brady Davis Joins Contextual Genomics’ Executive Team

Vancouver, Canada – January 8, 2020:  Contextual Genomics, a leading cancer genomics company, announced that it has named Brady Davis to its executive team. Mr. Davis, a veteran of the life sciences, healthcare and software industries, joins as Senior Vice President, Business Development of the Company, responsible for global strategy and business development.   Mr. Davis has more than 25 …

Contextual Main Account News

Contextual Genomics’ Scientific Founder Elected to Royal Society of Canada

Vancouver, Canada – September 24, 2019: Contextual Genomics Inc., a leading Canadian cancer genomics company headquartered in Vancouver, Canada, announced today that David Huntsman, MD, FRCPC, FCCMG, Chief Medical Officer and one of the Scientific Founders of Contextual Genomics has been elected a Fellow of the Royal Society of Canada (RSC), the highest honour a scholar can receive in the arts, …

Contextual Main Account News

Contextual Genomics Names Sue Paish as Chair of the Board of Directors

Vancouver, Canada – May 1, 2019: Contextual Genomics announced today that Sue Paish will become the new Chair of the Company’s Board of Directors effective May 1, 2019. Ms. Paish joined the Company’s Board of Directors in 2018 and is the former President and CEO of LifeLabs Medical Laboratory Services. Mr. Chris Wagner will be stepping down from his role …

Contextual Main Account News

Contextual Genomics Names Michael Ball as Chief Executive Officer

Vancouver, Canada – March 13, 2019:  Contextual Genomics, a leading Canadian cancer genomics company, announced today that its Board of Directors has named Michael Ball as Chief Executive Officer.  Mr. Ball was previously Global Vice President Commercial, Informatics, at Illumina, a market leader in the genomics industry.  Prior to Illumina, Mr. Ball was the CEO of GenoLogics Life Sciences Software, …

Contextual Main Account News

Contextual Genomics Launches Improved FIND IT Assay and New FOLLOW IT Assay

Vancouver, Canada – December 19, 2018:   Contextual Genomics Inc., a leading Canadian cancer genomics company headquartered in Vancouver, Canada, announces that it has completed development of two new products: (i) an improved version of its FIND IT™ hotspot panel for detection of genomic mutations in solid tumour cancers, and (ii)  its FOLLOW IT™ hotspot panel for detection of the same …

Contextual Main Account News

Contextual Genomics’ Scientific Founders Recognized for their Exceptional Research Contributions

Vancouver, Canada – December 7, 2018: Contextual Genomics Inc., a leading Canadian cancer genomics company headquartered in Vancouver, Canada, announces that its Scientific Founders, Drs. Samuel Aparicio, David Huntsman and Sohrab Shah, have been recognized by Web of Science (Clarivate Analytics) for their exceptional research performance, as determined by production of multiple highly cited papers that rank in the top …

Contextual Main Account News

Contextual Genomics Inc. receives funding from the Government of Canada

Vancouver, Canada – October 3, 2018:  Contextual Genomics Inc., a leading cancer genomics company, is pleased to announce that it has signed a contribution agreement with the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) for up to $500,000. The funding will support the development and validation of a newer expanded version of Contextual’s FIND ITTM somatic …

Contextual Main Account News

PacBridge Capital Partners (HK) Limited makes investment in Contextual Genomics Inc. – a Leading Canadian Cancer Genomics Company

Hong Kong S.A.R., China and Vancouver, Canada – February 23, 2018: PacBridge Capital Partners (HK) Limited, a Hong Kong based investment firm, has committed to a C$12,000,000 facility to fund Contextual Genomics Inc., a leading Canadian cancer genomics company headquartered in Vancouver, Canada. Contextual Genomics has developed FIND IT™, a proprietary molecular hotspot assay that screens for more than 140 …

Contextual Main Account News

Idengene SA to bring Contextual Genomics’ Revolutionary Cancer Genomic Test Find-It™ to Brazil

Sao Paulo, Brazil and Vancouver, Canada – November 9, 2017: Brazilian diagnostics company Idengene SA has partnered with leading Canadian cancer genomics company Contextual Genomics to bring Find-It™, a potentially revolutionary genomic test, to Brazil. Idengene will offer Find-It™ at its laboratory in Brazil to patients diagnosed with cancer. Under the terms of the distribution, license and services agreement, Idengene …

Contextual Main Account News

CORE Diagnostics ties up with Canada’s Contextual Genomics to bring its revolutionary genomic testing panel Find It™ to India

Find It™ screens for 120 genetic mutations in cancer patients CORE Diagnostics gets exclusive distributorship of Find It™ in India Will be marketed in India by the name of geneCORE Hotspot. New Delhi, India and Vancouver, Canada – August 9st 2017: Indian diagnostics start up CORE Diagnostics has tied up with leading Canadian company Contextual Genomics to introduce a potentially …

Contextual Main Account News

Contextual Genomics Receives DAP Accreditation for Testing and Informatics System

Vancouver, Canada – May 10, 2017 – Contextual Genomics Inc. (“Contextual”), developers of genomic cancer tests and computational systems, is pleased to announce it has received full accreditation from the Diagnostic Accreditation Program (DAP). Contextual is the first laboratory to receive full accreditation in Molecular Diagnostics from DAP. DAP, a program of the College of Physicians and Surgeons of British …